skip to main content

H.R. 2851: SITSA Act

Jun 15, 2018 at 11:24 a.m. ET. On Passage of the Bill in the House.

This was a vote to pass H.R. 2851 (115th) in the House.

More than 20,000 Americans died from synthetic drug overdoses in 2016. That represents 31 percent of all drug overdose deaths, a surging percentage in recent years — more than double the number from 2015.

A bill called the Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act aims to combat on the growing epidemic of synthetic drug deaths. But would it give Jeff Sessions too much power?

Context

There are more than 400 known types of synthetic — or “artificial” — drugs, which mimic the effects of substances including cocaine and ecstasy. They’ve largely begun to flood the market in recent years, this decade in particular.

The Drug Enforcement Agency (DEA), quite simply, cannot keep up. The bureaucratic process they follow when determining whether a drug should be put on the banned substances list, and what corresponding penalties should go along with each drug, can take several years of evaluation.

Advocates say the U.S. doesn’t have years.

What the bill does

The bill outlaws 13 different synthetic drugs of the most pernicious varieties, by creating a new “schedule” (a term for “categorization”) to the list of banned substances on the Controlled Substances Act. The list of the 13 drugs can be seen in section 2, subsection 3B here.

It also creates a process by which substances can be added — whether temporarily or permanently — in as little as 30 days after first being identified, rather than the years it can potentially take under current law. The lead House sponsor relayed a story during a committee hearing of a constituent from his New York district who died from overdosing on a synthetic drug which nonetheless remained legal for four years afterward.

Although the bill creates penalties for trafficking and distribution of these synthetic drugs, what the bill does not do is criminalize mere possession of such synthetic drugs. In this way, they intend to go after the proliferators rather than the users.

The bill was introduced in the House in June 2017 by Rep. John Katko (R-NY24), labelled as H.R. 2851. It was introduced in the Senate that same month by Sen. Chuck Grassley (R-IA), labelled as S. 1327.

What supporters say

Supporters argue the legislation will tackle a growing scourge in a far more timely and immediate manner than what the lagging DEA is usually able to accomplish.

“They can be more potent than the real thing and often times are more deadly. Unfortunately, when law enforcement encounters a specific synthetic drug compound, manufacturers of these substances are able to slightly alter the chemical structure of the drug,” House lead sponsor Katko said in a press release.

“This puts law enforcement at a serious disadvantage and are constantly one step behind them,” Katko continued. “As a former U.S. attorney, but more importantly, as a father, getting these drugs off the streets and out of the hands of our loved ones remains a top priority for me.”

What opponents say

Opponents argue the bill would too greatly expand Attorney General Jeff Sessions’ ability to criminalize drugs and impose unnecessarily punitive mandatory sentences. This week, Sessions announced a new policy cracking down on legal marijuana.

“Currently, for a drug to be scheduled and penalties applied, the Department of Justice must work in collaboration with public health officials at the Department of Health and Human Services, before deciding how to proceed. Each agency has equal weight when making decisions,” read a letter signed by dozens of organizations including the American Civil Liberties Union (ACLU), Human Rights Watch, and NAACP.

“Under this proposal, the public health role is circumvented, leaving the Attorney General with unilateral power to decide which drugs are scheduled and thus how the ensuing penalties are applied,” the letter continued. “To give the Attorney General this unbounded authority is troubling and misguided.”

Odds of passage

The bill has attracted a bipartisan mix of 54 House cosponsors: 49 Republicans and five Democrats. It awaits a possible vote in the House Judiciary Committee, whose Subcommittee on Crime, Terrorism, Homeland Security, and Investigations held a hearing on the bill in June. (The hearing can be viewed in full here.)

The Senate version has attracted a bipartisan mix of three cosponsors: two Democrats and one Republican. It awaits a possible vote in the Senate Judiciary Committee — though it seems more likely than not to get one, since Sen. Grassley who introduced the Senate version chairs the committee.

Totals

All Votes R D
Aye 63%
 
 
239
197
 
42
 
No 37%
 
 
142
12
 
130
 
Not Voting
 
 
46
25
 
21
 

Passed. Simple Majority Required. Source: house.gov.

Ideology Vote Chart

Key:
Republican - Aye Democrat - Aye Republican - No Democrat - No
Seat position based on our ideology score.

Cartogram Map

Each hexagon represents one congressional district. Solid hexes are Aye votes.

What you can do

Vote Details

Notes: The Speaker’s Vote? “Aye” or “Yea”?
Download as CSV

Statistically Notable Votes

Statistically notable votes are the votes that are most surprising, or least predictable, given how other members of each voter’s party voted and other factors.

All Votes

Study Guide

How well do you understand this vote? Use this study guide to find out.

You can find answers to most of the questions below here on the vote page. For a guide to understanding the bill this vote was about, see here.

What was the procedure for this vote?

  1. What was this vote on?
  2. Not all votes are meant to pass legislation. In the Senate some votes are not about legislation at all, since the Senate must vote to confirm presidential nominations to certain federal positions.

    This vote is related to a bill. However, that doesn’t necessarily tell you what it is about. Congress makes many decisions in the process of passing legislation, such as on the procedures for debating the bill, whether to change the bill before voting on passage, and even whether to vote on passage at all.

    You can learn more about the various motions used in Congress at EveryCRSReport.com. If you aren’t sure what the House was voting on, try seeing if it’s on this list.

  3. What is the next step after this vote?
  4. Take a look at where this bill is in the legislative process. What might come next? Keep in mind what this specific vote was on, and the context of the bill. Will there be amendments? Will the other chamber of Congress vote on it, or let it die?

    For this question it may help to briefly examine the bill itself.

What is your analysis of this vote?

  1. What trends do you see in this vote?
  2. Members of Congress side together for many reasons beside being in the same political party, especially so for less prominent legislation or legislation specific to a certain region. What might have determined how the roll call came out in this case? Does it look like Members of Congress voted based on party, geography, or some other reason?

    One tool that will be helpful in answering this question is the cartogram at the top of the page. A cartogram is a stylized map of the United States that shows each district as an identical hexagon. This view allows you to see the how the representatives from each district voted arranged by their geography and colored by their political party. What trends can you see in the cartogram for this vote?

  3. How did your representative vote?
  4. There is one vote here that should be more important to you than all the others. These are the votes cast by your representative, which is meant to represent you and your community. Do you agree with how your representative voted? Why do you think they voted the way they did?

    If you don’t already know who your Members of Congress are you can find them by entering your address here.

Each vote’s study guide is a little different — we automatically choose which questions to include based on the information we have available about the vote. Study guides are a new feature to GovTrack. You can help us improve them by filling out this survey or by sending your feedback to hello@govtrack.us.